Cancer Vaccines

Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2016 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 5th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more Join us this September for strategic direction on vaccine commercialisation and arm yourself with the key requirements and tools for successful vaccine development through informed guidance delivered by a top panel of speakers including Vaccinogen Inc, MSD, Genentech, Northwest Biotherapeutics, and more!